Cadus Pharmaceutical Corp. regulatory update

Cadus Pharmaceutical Corp. The Tarrytown, N.Y., company received U.S. Patent No. 5,405,941, a composition of matter patent covering the MEK kinase protein. The protein defines a new signal transduct...